Abstract
BackgroundProtecting infants against serogroup B meningococcal disease is a long-standing public health need. An investigational multicomponent vaccine (4CMenB) containing three recombinant proteins identified using whole-genome sequencing and outer membrane vesicles...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Archives of disease in childhood. Fetal and neonatal edition
Paper Title
Journal
Date
